Page results
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.
-
This page is for patients who have been referred by their GP to a gynaecology specialist because their symptoms need further tests.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Vascular Access team.
-
This booklet tells you about having a Vortex® Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Interventional Radiology team.
-
This page tells you about having a Non-Tunnelled CVC Line Insertion (Vascath). This page is for those patients who have been referred to Interventional Radiology.
-
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCLH, UCL and the Francis Crick Institute.
-
Temporary change to HIV confirmation pathway due to Bio-Rad kit supply issues
File results
-
FOI/2022/0686 - Breast cancer patients
-
FOI/2022/0672 - Data Centre
-
FOI/2022/0674 - Maternity locum staffing
-
FOI/2022/0675 - Drug treatment for Paediatric patients (ages 0-16)
-
FOI/2022/0677 - Documents relating to the lift being out of order (RLHIM Lift 2 by reception)
-
FOI/2022/0679 - Theatre management, AA's and ODPs
-
FOI/2022/0681 - Deep brain stimulation procedure
-
FOI/2022/0704 - Elective operations cancelled for non-clinical reasons
-
FOI/2022/0707 - Current endoscopy maintenance supplier and the contract expiry date
-
FOI/2022/0705 - Head/ neck and urothelial cancer treatment